Project Details
Description
Phase 2 Placebo-controlled Double blind Trial of Dasatinib added to Gemcitabine for Subjects with Locallyadvanced Pancreatic Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 2/17/11 → 7/30/15 |
Funding
- OTSUKA PHARMACEUTICAL DEV. & COMM., INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.